NEWS On the Health Affairs Blog: Sachs Reviews Key Provisions of FDA's User Fee Reauthorization Bill 5/15/17

In the latest post on the IVI-sponsored Health Affairs blog series, Rachel Sachs addresses key provisions of the FDA's proposed user fee authorization bill. Included in her assessment are details of new language changes and amendments added to the bill, as well as a look forward to potential obstacles to the bill's final passage.

Read more here.